Botond Tímár

687 total citations
34 papers, 355 citations indexed

About

Botond Tímár is a scholar working on Genetics, Pathology and Forensic Medicine and Hematology. According to data from OpenAlex, Botond Tímár has authored 34 papers receiving a total of 355 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Genetics, 17 papers in Pathology and Forensic Medicine and 14 papers in Hematology. Recurrent topics in Botond Tímár's work include Lymphoma Diagnosis and Treatment (15 papers), Chronic Lymphocytic Leukemia Research (11 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (9 papers). Botond Tímár is often cited by papers focused on Lymphoma Diagnosis and Treatment (15 papers), Chronic Lymphocytic Leukemia Research (11 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (9 papers). Botond Tímár collaborates with scholars based in Hungary, United States and Sweden. Botond Tímár's co-authors include András Matolcsy, Balázs Csernus, Ágota Szepesi, Zsolt Zoltán Fülöp, Csaba Bödör, Anna Sebestyén, Judit Csomor, Rudolf Mihalik, Terézia László and Gábor Barna and has published in prestigious journals such as Blood, Journal of Agricultural and Food Chemistry and The Journal of Pathology.

In The Last Decade

Botond Tímár

28 papers receiving 352 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Botond Tímár Hungary 11 176 156 114 112 77 34 355
Iwona Wlodarska Belgium 11 250 1.4× 233 1.5× 137 1.2× 96 0.9× 113 1.5× 14 441
Yuqin Song China 10 231 1.3× 202 1.3× 206 1.8× 111 1.0× 108 1.4× 65 443
Pascaline Etancelin France 9 162 0.9× 125 0.8× 92 0.8× 107 1.0× 72 0.9× 27 360
Junji Hiraga Japan 8 266 1.5× 142 0.9× 185 1.6× 119 1.1× 102 1.3× 17 464
Eisuke Shiozawa Japan 12 189 1.1× 69 0.4× 182 1.6× 75 0.7× 47 0.6× 39 366
Olivier Catalani Switzerland 11 116 0.7× 151 1.0× 198 1.7× 76 0.7× 48 0.6× 17 457
Eugene Zhu United States 8 155 0.9× 123 0.8× 164 1.4× 81 0.7× 30 0.4× 11 301
Keiichiro Hattori Japan 12 186 1.1× 96 0.6× 97 0.9× 68 0.6× 73 0.9× 35 346
Fontanet Bijou France 11 234 1.3× 217 1.4× 233 2.0× 117 1.0× 56 0.7× 46 467
Sarah C. Rutherford United States 12 260 1.5× 82 0.5× 199 1.7× 97 0.9× 64 0.8× 52 414

Countries citing papers authored by Botond Tímár

Since Specialization
Citations

This map shows the geographic impact of Botond Tímár's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Botond Tímár with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Botond Tímár more than expected).

Fields of papers citing papers by Botond Tímár

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Botond Tímár. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Botond Tímár. The network helps show where Botond Tímár may publish in the future.

Co-authorship network of co-authors of Botond Tímár

This figure shows the co-authorship network connecting the top 25 collaborators of Botond Tímár. A scholar is included among the top collaborators of Botond Tímár based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Botond Tímár. Botond Tímár is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Pinczés, László Imre, Botond Tímár, Márk Plander, et al.. (2025). Resistance mechanisms and clonal dynamics in mantle cell lymphoma treated with sequential BTKi and venetoclax therapy. The Journal of Pathology. 266(4-5). 395–404.
3.
Szepesi, Ágota, et al.. (2024). The significance of CD49f expression in pediatric B-cell acute lymphoblastic leukemia. American Journal of Clinical Pathology. 163(2). 169–177.
4.
Plander, Márk, et al.. (2024). Flow cytometry in the differential diagnosis of myelodysplastic neoplasm with low blasts and cytopenia of other causes. Pathology & Oncology Research. 30. 1611811–1611811. 1 indexed citations
5.
Nagy, Ákos, Gregory J. Hogan, Jacob J. Chabon, et al.. (2023). Phased Variants Allow Robust Profiling of Circulating Tumor DNA in Untreated Follicular Lymphomas. Blood. 142(Supplement 1). 1626–1626. 1 indexed citations
7.
Istenes, Ildikó, et al.. (2022). Case Report: Development of Diffuse Large B Cell Lymphoma a Long Time After Hairy Cell Leukemia. Pathology & Oncology Research. 28. 1610338–1610338. 1 indexed citations
9.
Farkas, Péter, Eid Hanna, Judit Demeter, et al.. (2021). Morphologic and molecular analysis of Richter syndrome in chronic lymphocytic leukaemia patients treated with ibrutinib or venetoclax. Pathology. 54(1). 95–103. 5 indexed citations
10.
Varga, Gergely, Gábor Mikala, László Gopcsa, et al.. (2018). Multiple Myeloma of the Central Nervous System: 13 Cases and Review of the Literature. Journal of Oncology. 2018. 1–7. 28 indexed citations
11.
Tímár, Botond, Tibor Krenács, Hussain Alizadeh, et al.. (2018). Calreticulin mutation specific CAL2 immunohistochemistry accurately identifies rare calreticulin mutations in myeloproliferative neoplasms. Pathology. 51(3). 301–307. 5 indexed citations
12.
Marschalkó, Márta, et al.. (2015). Altered MicroRNA Expression in Folliculotropic and Transformed Mycosis Fungoides. Pathology & Oncology Research. 21(3). 821–825. 30 indexed citations
13.
Tímár, Botond, Judit Hársing, Judit Csomor, et al.. (2015). CD8-positive mycosis fungoides: a case report. 91(1). 48–51. 1 indexed citations
14.
Sebestyén, Anna, Melinda Hajdu, Botond Tímár, et al.. (2012). Activity and complexes of mTOR in diffuse large B-cell lymphomas—a tissue microarray study. Modern Pathology. 25(12). 1623–1628. 24 indexed citations
15.
Barna, Gábor, Rudolf Mihalik, Botond Tímár, et al.. (2010). ROR1 expression is not a unique marker of CLL. Hematological Oncology. 29(1). 17–21. 62 indexed citations
16.
Balogh, Zsófia, Csaba Bödör, Botond Tímár, et al.. (2008). Somatic hypermutation of IGVH genes and aberrant somatic hypermutation in follicular lymphoma without BCL-2 gene rearrangement and expression. Haematologica. 93(12). 1822–1828. 16 indexed citations
17.
Csomor, Judit, et al.. (2008). Prolonged Survival Using Anti-CD20 Combined Chemotherapy in Primary Prostatic Intravascular Large B-cell Lymphoma. Pathology & Oncology Research. 14(3). 281–284. 11 indexed citations
18.
Fülöp, Zsolt Zoltán, Balázs Csernus, Botond Tímár, Ágota Szepesi, & András Matolcsy. (2003). Microsatellite instability and hMLH1 promoter hypermethylation in Richter’s transformation of chronic lymphocytic leukemia. Leukemia. 17(2). 411–415. 41 indexed citations
19.
Tímár, Botond, Zsolt Zoltán Fülöp, Balázs Csernus, et al.. (2003). Relationship between the mutational status of VH genes and pathogenesis of diffuse large B-cell lymphoma in Richter's syndrome. Leukemia. 18(2). 326–330. 33 indexed citations
20.
Balázs, Margit, et al.. (2000). Genetic instability is associated with histological transformation of follicle center lymphoma. Leukemia. 14(12). 2142–2148. 37 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026